Skip to main content

Cost analysis of pediatric intensive care: a low-middle income country perspective



Globally, Pediatric Intensive Care Unit (PICU) admissions are amongst the most expensive. In low middle-income countries, out of pocket expenditure (OOP) constitutes a major portion of the total expenditure. This makes it important to gain insights into the cost of pediatric intensive care. We undertook this study to calculate the health system cost and out of pocket expenditure incurred per patient during PICU stay.


Prospective study conducted in a state of the art tertiary level PICU of a teaching and referral hospital. Bottom-up micro costing methods were used to assess the health system cost. Annual data regarding hospital resources used for PICU care was collected from January to December 2018. Data regarding OOP was collected from 299 patients admitted from July 2017 to December 2018. The latter period was divided into four intervals, each of four and a half months duration and data was collected for 1 month in each interval. Per patient and per bed day costs for treatment were estimated both from health system and patient’s perspective.


The median (inter-quartile range, IQR) length of PICU stay was 5(3–8) days. Mean ± SD Pediatric Risk of Mortality Score (PRISM III) score of the study cohort was 22.23 ± 7.3. Of the total patients, 55.9% (167) were ventilated. Mean cost per patient treated was US$ 2078(₹ 144,566). Of this, health system cost and OOP expenditure per patient were US$ 1731 (₹ 120,425) and 352 (₹ 24,535) respectively. OOP expenditure of a ventilated child was twice that of a non- ventilated child.


The fixed cost of PICU care was 3.8 times more than variable costs. Major portion of cost was borne by the hospital. Severe illness, longer ICU stay and ventilation were associated with increased costs. This study can be used to set the reimbursement package rates under Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). Tertiary level intensive care in a public sector teaching hospital in India is far less expensive than developed countries.

Peer Review reports


Globally, Pediatric Intensive Care Unit (PICU) admissions are amongst the most expensive of all hospital admissions. They significantly impact the financial dynamics of patient’s families. Although intensive care beds comprise only about 10% of hospital beds, they account for 20–40% of all hospital costs especially in the high income countries [1]. However, health insurance coverage and availability of drugs and consumables from hospital supplies ease financial burden for patient’s families. The scenario in low middle-income countries (LMIC) like India is different; cost of health care services is borne by both government as well as patients. According to National Health Accounts guidelines of our country, out of pocket expenditure (OOP) constitutes 68 to 70% of the total expenditure [2]. The OOP for families whose children are admitted to intensive care units is very high. The Indian government launched the Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), a health insurance scheme in September 2018 with the aim to cover 50 crore people [3]. However, the health benefit package (HBP) rates in this scheme are low due to lack of reference on costing data in India. The existing packages were determined through a consultative process with experts and a review of existing health insurance schemes. A problem with such charge-based reimbursement rates is that they do not capture the actual cost and resource use. Health Technology Assessment India (HTAIn) commissioned a national costing study entitled ‘Cost of Health Services in India’ (CHSI) for information regarding reimbursement rates of HBPs under AB - PMJAY and for use in economic evaluations [4]. PM – JAY focuses on costing data from Level III care as Level II estimates are already available.

Although there have been few studies from India on cost analysis of neonatal intensive care, cost analysis of PICU care and the financial impact on the families of children receiving such care in India is limited.

Our multispecialty public sector pediatric hospital caters to a large volume of referrals from 5 to 6 north western states of our country viz. Haryana, Punjab, Himachal Pradesh, Uttar Pradesh, Jammu &Kashmir and Rajasthan and provides comprehensive care to these children. The PICU in our hospital offers state of the art Level III intensive care services to critically ill children referred from the regions.

Cost analysis from such a set up looking at both health system as well as patient’s perspective would provide insight into the financial burden and its impact on hospital and communities.

Also, the data generated through this study will help in budget planning, allocation, effective utilisation of resources and can serve as a benchmark for other similar ICUs. More importantly, in the context of economic evaluations, costing studies from tertiary care centres like ours can help in revising rates of many health benefit packages.


Study setting

We undertook this prospective observational cross-sectional study in our 15 bedded Level III PICU which has an annual admission average of 900 to 1000 patients. It has state of the art respiratory, hemodynamic and multimodal neuromonitoring facilities. Diagnostics such as echocardiography, X-ray, ultra-sonography, and arterial blood gas monitoring are available round the clock. While provisions for intracranial pressure monitoring, haemodialysis and continuous renal replacement therapy exist, ECMO is not available. A total of 912 patients were admitted in the PICU during 2018.

Study design

In low middle-income countries, cost of health care services is borne by both government as well as patients. According to National Health Accounts guidelines of our country, OOP constitutes 68 to 70% of the total expenditure [2]. Therefore, we undertook this study from a societal perspective and estimated both health system and out of pocket expenditure to assess the overall cost of provision of intensive care services.

Health system cost

We used a combination of both top down and bottom up approach for micro costing [5,6,7,8,9]. The cost of human resources, infrastructure, equipment, physical space and overheads were estimated using the top down approach. Costing of drugs and consumables and diagnostics was calculated using the bottom up method.

Resource identification

Annual data regarding hospital resources utilized for the PICU care was collected from January 2018 to December 2018. We chose 1 year period to iron out any difference in volume and type of patients who access these services. All resources were classified as recurrent and capital resources. Recurrent costs are the costs of maintaining and operating a unit once the initial investment has been completed. Human resources, diagnostics, consumables and overhead costs (i.e. water consumption, electricity and dietetics etc.) comprised recurrent costs. Capital costs occur one time and are unlikely to recur again. Costs of building or space, medical and non - medical equipment and furniture were part of capital costs.

Resource measurement

The methodology for data collection included reviewing records, staff interviews and physical inspection of facility. The collected data included number of human resources (i.e. medical and paramedical staff, administrative and support staff), space in the building, number and types of equipment, other non-consumable items, diagnostic tests (laboratory and radiological), medicines, consumables and other overhead costs. Data was collected on the quantity of different resources being exclusively used in PICU.

Staff members were interviewed to obtain information on the time spent by them in PICU and further annual salary was apportioned to number of working days in PICU. Pretested questionnaires used in previous Indian studies were used [10,11,12,13]. Stock registers of PICU served as major source for data regarding quantities of consumables and non-consumables and annual cost was calculated by annual amount and price data. The actual cost of diagnostic services was 3.04 times higher than what was charged to patients and hence calculated by multiplying each investigation charge by a factor (3.04) thereby converting the user fee into total cost of diagnostics [14]. Data for the overhead costs was collected by record review of electricity bills and water bills.

Resource valuation

Hospital’s procurement branch had provided the data regarding capital costs, including the year of purchase and price of medical and non-medical equipment [10, 14]. Technical officer in – charge of PICU was interviewed to elicit information regarding average life of the equipment. Apart from this, literature was reviewed to cross validate for the life of capital items.

Out of pocket expenditure

Data regarding expenditure borne by the patient families for bed charges, medicines, and investigations for their ward’s treatment in PICU and transportation and meals of attendants was collected by a daily interview till the discharge or transfer or final outcome of the patient. In order to have data representative of entire duration, the study period of one and a half years from July 2017 to December 2018, was divided into four intervals, each of 4 and a half months duration. Data was collected for 1 month in each interval wherein children > 1 month to 12 years admitted in PICU during that interval were enrolled consecutively.

Written and informed consent was obtained from the parents before eliciting information related to OOP. We also collected data on socio-demographic characteristics of the families of the patient admitted, which included education and occupation of the head of the family and per capita income. Information regarding methods to cope with treatment expenses and salary losses were elicited using questionnaire.

To correlate cost with severity of illness, Pediatric Risk of Mortality Score (PRISM III Score) validated from Physiologic Stability Index (PSI) was calculated for every patient within 24 h of admission to PICU [15]. Patients were divided into 5 groups based on their PRISM III Score such as 0–10, 11–20, 21–30, 31–40, 41 and above. Subsequently average total out of pocket expenditure per patient within each group was calculated.

Data analysis

Health system costs

Data analysis was done using Statistical Package for Social Sciences (SPSS) version 25 and MS Excel. The cost of the PICU space / building was estimated by applying rental price for the area. Annualized costs of various medical and non-medical equipment in the PICU were estimated based on their average useful life and application of an average discount rate. A discount rate of 3% was used to compute the annualization factor [16]. Methodological guidelines for conduct of economic evaluation published by the Department of Health Research in India recommend a 3% discount rate for valuing future costs and outcome [17]. In the systemic review of economic evaluation in India, 3% discount rate was accounted as the most prevalent practice adopted by them [18]. Further, most recent costing studies and economic evaluation in India have recommended and used 3% discount rate for computing annual cost [19,20,21]. All the cost estimates were finally converted to 2018 prices to adjust for inflation, applying a discounting factor of 3% per year.

Apportioning statistics

Appropriate apportioning statistics were used to allot shared or joint resources to the PICU. Firstly, for the human resources, we interviewed people involved in PICU services, which mainly included consultants, residents, nursing officers and technical staff to obtain data on patterns of work flow and time devoted to PICU. Proportion of time spent in PICU care was used to apportion the shared human resource costs.

Secondly, costs of shared building/space (i.e. waiting hall, discussion room, residents’ room, nursing station, laboratory etc.), overheads and equipment were apportioned on the basis of bed-days of PICU patients in a year. Cost of medicines and consumables was estimated for PICU alone and hence this was not a shared cost so there was no requirement of apportioning.

Unit costs

The health system costs were summated and calculated as Annual Health System Cost and then divided by the total number of patients admitted in the study year (2018) to calculate the average health system cost per patient. Sources of data are described in Table 1.

Table 1 Sources of data and apportioning statistics for Pediatric Intensive care unit type of data

Further, per patient health system cost was calculated by dividing total annual cost by total bed days of length of stay per patient.

Out of pocket expenditure

We estimated the mean and standard error of OOP expenditure from the data collected from the patients. Descriptive statistics [frequencies and proportions, mean ± standard deviation (SD) and Median (IQR)] were used for baseline data analysis. Chi Square test, Fisher exact test and Mann – Whitney test were used to calculate relation between relevant parameters.

Sensitivity analysis

Univariate sensitivity analysis was undertaken to evaluate the influence of parameter uncertainties on total costs. Salaries for human resources, prices of drugs, equipment, and rental costs were varied by 25, 50, 25 and 25% respectively on either side of the base value. In order to assess the effect of discount rate on the total annual cost of pediatric intensive care, the discount rate was also varied from 0 to 5%.


Sample characteristics

A total of 299 children were enrolled for the estimation of OOP. The median (IQR) age of the study subjects was 4 years (0.8 to 12 years). Of all patients, boys represented 63.5% (190). The median (IQR) length of PICU stay was of 5 days (3–8 days). Nearly half of the parents had completed middle and high school education. Only 21(7%) and 7(2.3%) were graduates and post graduates respectively. Socio economic status classification according to Kuppuswami Scale 2018, showed that 288 (96.5%) of admitted children belonged to the lower middle and upper lower socio-economic strata. Out of them 49.8% were labourers and daily wage workers, 44.8% were self-employed and only 5% were salaried personnel. Around 85% patients were discharged or transferred to wards from PICU, while forty-six patients had died (Table 2). The mean ± SD PRISM III score was 22.2 ± 7.3 with maximum score being 46. Common indications for PICU admission were respiratory (40.8%), followed by hemodynamic needs (19.7%) and combined in the rest. Among the diagnostic categories, tropical fevers (dengue, scrub typhus, malaria, enteric fever) were the commonest (n = 51; 17%), followed by community acquired pneumonia (n = 50; 16.7%), acute meningoencephalitis (n = 42; 14%), disseminated staphylococcal sepsis (n = 32; 10.7%), acute bronchiolitis (n = 20; 6.6%), poisoning and envenomation (n = 19; 6.3%), acute meningitis(n = 13; 4.3%), acute gastroenteritis(n = 10; 3.3%) and others (n = 69; 20.7%) (Table 4).

Table 2 Characteristics and out of pocket expenditure of patients admitted to Level III PICU

Health system costs

The total health system cost incurred to treat 912 children in PICU during the year 2018, was estimated to be US$ 1,578,900 (₹109,844,073). Share of human resources was the highest (58.6%), followed by Capital space (16%) and Equipments (15.6%). The total mean cost per patient treated and per bed-day in the PICU was found to be US$ 2078 (₹144,566) and 415 (₹ 28,871) respectively. Of this, the mean health system cost per patient and per bed day was US$ 1731 (₹120,425) and 346 (₹24,071) respectively. Table 3 depicts Annual and unit health system costs and total costs for patients admitted in PICU.

Table 3 Annual health system costs and unit costs of treatment of patients in Level III PICU

Out of pocket expenditure

The mean OOP expenditures for treatment in PICU was US$ 352 (95% CI 315–390) as shown in Table 2. Medicines and consumables accounted for a major share of OOP expenditure i.e. 79% (Fig. 1). Mean OOP expenditures per patient and per patient bed day was US$352 (₹ 24,535) and US$70 (₹4897). Mean OOP expenditures for ventilated patient was significantly higher than a non-ventilated [US$ 466 (₹32,482) vs US$ 208 (₹14,482); p < 0.001]. Similarly, the OOP expenditure in patients with PICU stay of ≤2 days was US$ 210 (₹14,653), which was almost one third of the OOP expenditure among patients with PICU stay of > 2 days i.e. US$ 503 (₹ 35,032) (Table 2).

Fig. 1

Determinants (%) of out of pocket expenditure of patients admitted in Level III PICU

We categorised our study patients into 5 groups based on their PRISM III such as 0–10, 11–20, 21–30, 31–40, 41 and above. Correlating the severity of illness with OOP, we found that average OOP per patient with PRISM III between ‘11 – 20’ was US$ 235 (₹16,376) which was significantly less as compared to patients with PRISM III 21 and above US$ 413 (₹28,765) (Table 2). Additional analysis was undertaken to estimate the mean OOP expenditure for a particular diagnostic category. Out of pocket expenditure was maximum for acute meningoencephalitis ranging from US$ 244 to 707 (₹16,985–49,142). Mean (SE) and Median values are shown in Table 4.

Table 4 Diagnostic categories and out of pocket expenditure of patients admitted to level III PICU

Sensitivity analysis

Sensitivity analysis revealed that, total annual costs were most sensitive to variation in human resource costs followed by capital, equipment and medicines and consumables as shown in Tornado diagram (Fig. 2). We also found that variation in discount rate, was associated with an increase of total cost by 20% (undiscounted) to a decrease by16% (discount rate of 5%).

Fig. 2

Tornado diagram showing sensitivity analysis


Globally PICU admissions are most expensive and have significant impact on financial dynamics of patient families. India, being a lower middle-income country, financial burden on most of the middle class families is beyond their reach and far more than their family income. Lack of health care insurance and government health care support in most places increases the financial burden further. Our findings revealed that 80% of the total cost incurred to a patient when cared for in PICU was borne by the hospital and only 20% by the patient. This finding is opposite to the general patterns of health care financing wherein nearly 70% of total health care costs are borne by out-of-pocket by patients [22]. Of the health system cost, the major expenditure was towards staff salaries (58.6%) followed by physical space and infrastructure (16%), equipment (15.6%), diagnostics (6.4%), and the rest by drugs and consumables (hospital supply), non-medical equipment charges and overheads. Staff salaries contribute to the major chunk of expenditure because of the higher number of doctors and nurses deployed in PICU. Study by Moerer et al. had also found cost of staffing to be the highest expenditure in intensive care [23]. A study in a neonatal intensive care unit by Narang et al. had also shown similar results; personnel salary constituted 55% of the running costs [10]. A French study by Garcia et al., also had shown much higher proportion of salary cost, 82% of ICU budget was consumed by staff cost [24].

The out of pocket expenditure per patient in our study constituted approximately 20% of the total PICU cost per patient. Although a significant proportion of supplies are provided by the hospital, being a public sector hospital and comparatively cheaper, it is overburdened with large volume of patients. Most patients belonged to the lower middle and upper lower socio-economic strata and more than half were daily wage workers who earned about US$ 100–200 per month. Hence they depend on public sector hospitals for healthcare. Although the OOP, was low compared to international standards, it still translates into significant cost burden for our economically disadvantaged patients.

The OOP in a ventilated patient was double that of a non-ventilated child. Mechanical ventilation requires increased diagnostic and therapeutic procedures, invasive monitoring and drugs and other consumables, thus escalating the cost per patient. Shweta et al. had shown that at all levels of care, the most expensive were those requiring mechanical ventilation [25]. Similar findings were reported in the study by Moerer et al. [23]

We found that the costs of intensive care in PRISM III group of ‘11 – 20’ was significantly less as compared to PRISM III group above 20. However, the cost incurred was similar between PRISM III group ‘21 – 30’, ‘31–40’ and ‘41 and more’. This is explained by the fact that children with PRISM III score above 20 are all severely sick and hence their intensive care needs and cost involved will be similar. Garcia et al. in their study comparing Physiological Stability Index (PSI) with costing had found that increase in PSI on day 1 was associated with increased cost of investigations and treatment [24].

Length of ventilation and PICU stay correlated with the OOP; average OOP in a patient with PICU stay of < 2 days was almost one third the average cost of patients with PICU stay of > 2 days. Similar findings were reported by Chalom et al. where the length of stay had the strongest correlation with the average cost per patient [26].

It has been reported that low reimbursement rates under insurance programmes results in a practice of “balance billing” i.e. the hospitals charge the remaining amount to the patients [27]. This leads to patients continuing to pay out of pocket expenditures for a care which is entitled to be free. As a result empirical cost analysis study like ours will guide policy for price setting [28].

Estimation of health system cost for each diagnostic category and procedures apart from ventilation was not possible due to the methodology of data collection. However, the unit health system cost along with the volume of service utilisation based on standard treatment guidelines and estimates of OOP expenditure for each diagnostic category may help to derive provider payment rates of different packages under (AB-PMJAY) scheme. Furthermore, the indirect cost incurred as a result of lost productivity due to care giver’s time was not measured. None of the government programmes reimburse the indirect costs incurred for treatment.

The Department of Health Research has commissioned a nationally representative study to estimate the cost of health care services for setting the reimbursement rates under AB-PMJAY [3]. The cost estimates from this study published recently showed wide discrepancy between the actual cost of providing services and what is actually paid under the health insurance programme [29]. However, these estimates do not include the cost of providing pediatric services.

There are few published estimates for cost of pediatric intensive care. However these studies are either too dated or have been undertaken in secondary care settings (Level II ICU) [10, 30].

Our study was done in a tertiary level PICU which has one of the best intensive care facilities available at an affordable cost in a public sector hospital. In developing countries, cost of ICU care in public is much less than corporate sector hospitals. A study from another tertiary care teaching hospital in our country had shown similar cost analysis; total cost per patient and per day cost amounted to US$ 1705 and US$ 229 respectively [31]. However, unlike our hospital, the total cost is completely borne by the patient families.

Compared to the cost of intensive care in developed nations, ICU costs are low in the developing countries. A study done by Children’s Hospital of Philadelphia USA, had shown total cost for a patient admitted to PICU amounted to $12,342 while per day per patient cost amounted to $2264 [26]. Similarly, a study from a teaching university hospital of Thessaly, Greece showed mean actual cost per ICU patient to be 16,516, actual reimbursement from social funds was only 1671 [32]. A study by Moran et al. in Queen Elizabeth Hospital, Australia, on cost calculation in adult intensive care unit showed that the median cost per patient was AUS$2534 (range AUS$106 to AUS$95602) [33]. This low cost of ICU care in India is partly attributed to low cost of drugs, recycling of consumables and lower staff salaries.

To the best of our knowledge, this is the first study of its kind, to address the detailed cost analysis of a tertiary level PICU care in a public sector hospital. The strength of our study lies in our robust cost calculation that has taken into account all the fixed and variable costs. This study can therefore act as a benchmark for other similar PICU’s and for planning cost minimisation trials.

We acknowledge a few limitations of our study. First, the time bound nature of the study dictated a small sample size and limited period of evaluation. Second, health system cost was apportioned uniformly for each patient and was not calculated individually as per their severity of illness and different procedures required (intracranial pressure monitoring, haemodialysis or continuous renal replacement therapy). Third, cost of liaison consultation has not been included in the costing process of the study. Lastly, since cost assessment was done from a single PICU, a sensitivity analysis could not be done with respect to delivery strategy.


Pediatric ICU health system costs are 3.8 times more than the Out of Pocket expenditure in a public sector hospital. Severe illness, need for ventilation and duration of mechanical ventilation and longer ICU stay, were associated with increased costs of PICU care. This study can guide setting of the reimbursement package rates under AB-PMJAY. Tertiary level intensive care in India is far less expensive than developed countries. Intensive care in public sector is affordable compared to corporate sector hospitals.



Pediatric intensive care unit


Out of pocket expenditure


Inter quartile range


Pediatric risk of mortality sore


Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana


Extra corporeal membrane oxygenation


Statistical Package for Social Sciences


Physiological Stability Index


Health Technology Assessment India


Low middle-income countries


Health benefit package


Cost of Health Services in India


  1. 1.

    Thompson DI. Reducing ICU costs with computerized tools. Healthc Financ Manage. 1995;49(6):66 68–70.

    CAS  PubMed  Google Scholar 

  2. 2.

    National Health Accounts | National Health Systems Resource Centre, MoHFW, Government of India [Internet]. [cited 2020 Nov 9]. Available from:

  3. 3.

    Prinja S, Singh MP, Guinness L, Rajsekar K, Bhargava B. Establishing reference costs for the health benefit packages under universal health coverage in India: cost of health services in India (CHSI) protocol. BMJ Open. 2020;10(7):e035170.

    Article  Google Scholar 

  4. 4.

    Prinja S, Brar S, Singh MP, Rajsekhar K, Sachin O, Naik J, et al. Process evaluation of health system costing - experience from CHSI study in India. PLoS One. 2020;15(5):e0232873.

    CAS  Article  Google Scholar 

  5. 5.

    Adamiak G. Methods for the economic evaluation of health care programmes, 3rd ed. J Epidemiol Community Health. 2006;60(9):822–3.

    PubMed Central  Google Scholar 

  6. 6.

    Jana A, Basu R. Examining the changing health care seeking behavior in the era of health sector reforms in India: evidences from the National Sample Surveys 2004 & 2014. Glob Health Res Policy. 2017;2:6.

    Article  Google Scholar 

  7. 7.

    Chauhan AS, Prinja S, Ghoshal S, Verma R, Oinam AS. Cost of treatment for head and neck cancer in India. PLoS One. 2018;13(1):e0191132.

    Article  Google Scholar 

  8. 8.

    Costing of health services for provider payment: a practical manual | joint learning network [Internet]. [cited 2021 Jan 15]. Available from:

  9. 9.

    DeCormier PW, Bollinger LA, Alexander L, Cameron DB, Carroll LN, Cunnama L, et al. Developing the Global Health cost consortium unit cost study repository for HIV and TB: methodology and lessons learned. Afr J AIDS Res. 2019;18(4):263–76.

    Article  Google Scholar 

  10. 10.

    Prinja S, Manchanda N, Mohan P, Gupta G, Sethy G, Sen A, et al. Cost of neonatal intensive care delivered through district level public hospitals in India. Indian Pediatr. 2013;50(9):839–46.

    Article  Google Scholar 

  11. 11.

    Prinja S, Sharma Y, Dixit J, Thingnam SKS, Kumar R. Cost of treatment of Valvular heart disease at a tertiary Hospital in North India: policy implications. Pharmacoecon Open. 2019;3(3):391–402.

    Article  Google Scholar 

  12. 12.

    Sangwan A, Prinja S, Aggarwal S, Jagnoor J, Bahuguna P, Ivers R. Cost of trauma Care in Secondary- and Tertiary-Care Public Sector Hospitals in North India. Appl Health Econ Health Policy. 2017;15(5):681–92.

    Article  Google Scholar 

  13. 13.

    Prinja S, Gupta A, Verma R, Bahuguna P, Kumar D, Kaur M, et al. Cost of delivering health Care Services in Public Sector Primary and Community Health Centres in North India. PLoS One. 2016;11(8):e0160986.

    Article  Google Scholar 

  14. 14.

    Prinja S, Bahuguna P, Duseja A, Kaur M, Chawla YK. Cost of intensive care treatment for liver disorders at tertiary care level in India. Pharmacoecon Open. 2018;2(2):179–90.

    Article  Google Scholar 

  15. 15.

    Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med. 1988;16(11):1110–6.

    CAS  Article  Google Scholar 

  16. 16.

    Drummond M, Sculpher M. Common methodological flaws in economic evaluations. Med Care. 2005;43(7 Suppl):5–14.

    PubMed  Google Scholar 

  17. 17.

    Chugh Y, Dhiman RK, Premkumar M, Prinja S, Singh Grover G, Bahuguna P. Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India. PLoS One. 2019;14(8):e0221769.

    CAS  Article  Google Scholar 

  18. 18.

    Prinja S, Chauhan AS, Angell B, Gupta I, Jan S. A systematic review of the state of economic evaluation for health care in India. Appl Health Econ Health Policy. 2015;13(6):595–613.

    Article  Google Scholar 

  19. 19.

    Chauhan AS, Prinja S, Srinivasan R, Rai B, Malliga JS, Jyani G, et al. Cost effectiveness of strategies for cervical cancer prevention in India. PLoS One. 2020;15(9):e0238291.

    CAS  Article  Google Scholar 

  20. 20.

    Bahuguna P, Prinja S, Lahariya C, Dhiman RK, Kumar MP, Sharma V, et al. Cost-effectiveness of therapeutic use of safety-engineered syringes in healthcare facilities in India. Appl Health Econ Health Policy. 2020;18(3):393–411.

    Article  Google Scholar 

  21. 21.

    Gupta N, Verma RK, Gupta S, Prinja S. Cost effectiveness of Trastuzumab for Management of Breast Cancer in India. JCO Glob Oncol. 2020;6:205–16.

    Article  Google Scholar 

  22. 22.

    Bahuguna P, Mukhopadhyay I, Chauhan AS, Rana SK, Selvaraj S, Prinja S. Sub-national health accounts: experience from Punjab state in India. PLoS One. 2018;13(12):e0208298.

    Article  Google Scholar 

  23. 23.

    Moerer O, Plock E, Mgbor U, Schmid A, Schneider H, Wischnewsky MB, et al. A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units. Crit Care (London, England). 2007;11(3):R69.

    Article  Google Scholar 

  24. 24.

    García S, Ruza F, Alvarado F, Madero R, Delgado MA, Dorao P, et al. Analysis of costs in a pediatric ICU. Intensive Care Med. 1997;23(2):218–25.

    Article  Google Scholar 

  25. 25.

    Shweta K, Kumar S, Gupta AK, Jindal SK, Kumar A. Economic analysis of costs associated with a respiratory intensive care unit in a tertiary care teaching hospital in northern India. Indian J Crit Care Med. 2013;17(2):76–81.

    Article  Google Scholar 

  26. 26.

    Chalom R, Raphaely RC, Costarino AT. Hospital costs of pediatric intensive care. Crit Care Med. 1999;27(10):2079–85.

    CAS  Article  Google Scholar 

  27. 27.

    Prinja S, Chauhan AS, Karan A, Kaur G, Kumar R. Impact of publicly financed health insurance schemes on healthcare utilization and financial risk protection in India: a systematic review. PLoS One. 2017;12(2):e0170996.

    Article  Google Scholar 

  28. 28.

    Prinja S, Chauhan AS, Rajsekhar K, Downey L, Bahuguna P, Sachin O, et al. Addressing the cost data gap for universal healthcare coverage in India: a call to action. Value Health Reg Issues. 2020;21:226–9.

    Article  Google Scholar 

  29. 29.

    Prinja S, Singh MP, Rajsekar K, Sachin O, Gedam P, Nagar A, et al. Translating research to policy: setting provider payment rates for strategic purchasing under India’s National Publicly Financed Health Insurance Scheme. Appl Health Econ Health Policy. 2021;19:1–18.

    Article  Google Scholar 

  30. 30.

    Narang A, Kiran PSS, Kumar P. Cost of neonatal intensive care in a tertiary care center. Indian Pediatr. 2005;42(10):989–97.

    PubMed  Google Scholar 

  31. 31.

    Peter JV, Thomas K, Jeyaseelan L, Yadav B, Sudarsan TI, Christina J, et al. Cost of intensive care in India. Int J Technol Assess Health Care. 2016;32(4):241–5.

    Article  Google Scholar 

  32. 32.

    Geitona M, Androutsou L, Theodoratou D. Cost estimation of patients admitted to the intensive care unit: a case study of the Teaching University hospital of Thessaly. J Med Econ. 2010;13(2):179–84.

    Article  Google Scholar 

  33. 33.

    Moran JL, Peisach AR, Solomon PJ, Martin J. Cost calculation and prediction in adult intensive care: a ground-up utilization study. Anaesth Intensive Care. 2004;32(6):787–97.

    CAS  Article  Google Scholar 

Download references





Author information




1. AK – Design, acquisition, data analysis and interpretation and drafting of manuscript (Affiliation- Department of Pediatrics, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India – 160012). 2. MJ – Corresponding author, design, acquisition, data analysis, interpretation of data, drafting and revision of manuscript (Affiliation- Department of Pediatrics, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, India – 160012). 3. SP – Design, conception, drafting and revision of manuscript (Affiliation- Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, India – 160012). 4. RS – Data acquisition, interpretation of data (Affiliation – Department of Hospital Administration, Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, India – 160012). 5. AB – Revision of manuscript – (Affiliation- Department of Pediatrics, Advanced Pediatric Centre, Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, India – 160012). All authors have read and approved the manuscript.

Corresponding author

Correspondence to Muralidharan Jayashree.

Ethics declarations

Ethics approval and consent to participate

Ethics approval was taken from the Ethics Committee of the Post Graduate Institute of Medical Education and Research, Chandigarh India.

A written consent was taken from parents. The Ethics Committee had given approval as per the requirements in the protocol.

Reference number: NK/3846/MD/dated 23.12.2017

Consent for publication

Departmental Consent for publication was taken (Reference number: DRB - 44 -19; dated 13.02.2020).

Competing interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kaur, A., Jayashree, M., Prinja, S. et al. Cost analysis of pediatric intensive care: a low-middle income country perspective. BMC Health Serv Res 21, 168 (2021).

Download citation


  • Cost analysis
  • Expenditure
  • Pediatric intensive care
  • Tertiary care